article thumbnail

Need investment capital?

Berkonomics

Preparing for the game… If you have been following our recent insights, you’ll be up to speed knowing that professional investors negotiate tough terms, from provisions of control over asset acquisition, eventual sale of the company, future investments, forced co-sale when others attempt to sell their shares and more.

Invest 296
article thumbnail

Beyond Meat prices its public offering

TechCrunch LA

Beyond Meat , the meat replacement company whose packages of Beyond Burgers line grocery store aisles across America, has priced its initial public offering. Another winner from the Beyond Meat public offering is the corporate investment arm of Tyson Foods. The meat processor and marketer invested in Beyond Meat back in 2016.

Pricing 236
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

GoodRx Prices IPO

socalTECH

Santa Monica-based prescription and healthcare marketplace operator GoodRx has priced its IPO, saying late last night that it is offering up 34,615,384 shares of its Class A common stock at $33.00 The company priced well above its initial offering range, which was $24.00 per share, indicating high investor interst in the company.

Pricing 113
article thumbnail

Avidity Biosciences Prices IPO

socalTECH

San Diego-based Avidity Bio , a biopharmaceuticals company working on oligonucleotide-based therapies, priced its IPO last night, saying that it will offer up 14,400,000 shares of its common stock at $18.00 The company priced above its initial estimated offering range of $14.00 READ MORE>>.

Pricing 113
article thumbnail

Bad Notes on Venture Capital

Both Sides of the Table

On the phone … Me: So, you raised venture capital? Me: At what price? Him: It wasn’t priced. So you did raise with a price. It’s just a maximum price. Him: But when I raised my first round we didn’t know how to price the company. How will you price the next round? Your A round?

article thumbnail

GoodRx Sets IPO Pricing Range

socalTECH

Santa Monica-based GoodRx , a developer of a digital healthcare and prescriptions service, has set an IPO pricing range of between $24.00 and $28.00 The company is looking to raise as much as $1.1 billion through its IPO on the NASDAQ Global Select Market. GoodRx has filed to trade as GDRX. Seelaus & Co., LLC and Ramirez & Co.,

article thumbnail

Avidity Biosciences Sets IPO Pricing Range

socalTECH

La Jolla-based Avidity Biosciences , which is developing oligonucleotide-based therapies for rare and serious diseases, has set the pricing range for its IPO, saying it is looking to sell 10 million shares at between $14.00 and $16.00 The company said it has applied to list on the Nasdaq Global Market as RNA. READ MORE>>.

Pricing 113